Literature DB >> 11153910

Molecular defects in the alpha-N-acetylglucosaminidase gene in Italian Sanfilippo type B patients.

A Tessitore1, G R Villani, C Di Domenico, M Filocamo, R Gatti, P Di Natale.   

Abstract

Sanfilippo syndrome type B (mucopolysaccharidosis IIIB) is a rare autosomal recessive disorder characterized by the inability to degrade heparan sulfate because of a deficiency of the lysosomal enzyme alpha-N-acetylglucosaminidase (NAGLU). We performed mutation screening in a group of 20 patients, identyifing 28 mutations, 14 of which were novel (L35F, 204delC, 221insGCGCG, G82D, W156C, 507delC, IVS3+1G-->A, E336X, V501G, R520W, S534Y, W649C, 1953insGCCA, 2185delAGA). Four of these mutations were found in homozygosity and only one was seen in two different patients, showing the remarkable molecular heterogeneity of the disease. Mutation IVS3+1G-->A produces aberrant RNA splicing: it represents a base substitution from G to A of the invariant GT dinucleotides at the splicing donor site of intron 3 resulting in the skipping of exon 3 and both exons 2 and 3. Transient transfection of COS cells, by DNA mutagenized with NAGLU mutations, produced enzymatic molecules without activity, demonstrating the deleterious nature of the defects. Metabolic labeling of transfected mutants suggested a normal synthesis of the involved polypeptide for missense alterations, whereas increased protein or mRNA instability was shown for nonsense and most of the frameshift mutations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11153910     DOI: 10.1007/s004390000429

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  26 in total

1.  Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE.

Authors:  B Budowle; R Chakraborty; A M Giusti; A J Eisenberg; R C Allen
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

Review 2.  Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells.

Authors:  A Jacobson; S W Peltz
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

3.  Defects in RNA splicing and the consequence of shortened translational reading frames.

Authors:  L E Maquat
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

4.  Modification of a PCR-based site-directed mutagenesis method.

Authors:  C L Fisher; G K Pei
Journal:  Biotechniques       Date:  1997-10       Impact factor: 1.993

5.  Two-exon skipping due to a point mutation in p67-phox--deficient chronic granulomatous disease.

Authors:  M Aoshima; H Nunoi; M Shimazu; S Shimizu; O Tatsuzawa; R T Kenney; S Kanegasaki
Journal:  Blood       Date:  1996-09-01       Impact factor: 22.113

6.  'Cold SSCP': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses.

Authors:  T Hongyo; G S Buzard; R J Calvert; C M Weghorst
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

7.  Genotype-phenotype correspondence in Sanfilippo syndrome type B.

Authors:  H G Zhao; E L Aronovich; C B Whitley
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

8.  NAGLU mutations underlying Sanfilippo syndrome type B.

Authors:  A Schmidtchen; D Greenberg; H G Zhao; H H Li; Y Huang; P Tieu; H Z Zhao; S Cheng; Z Zhao; C B Whitley; P Di Natale; E F Neufeld
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

9.  Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C).

Authors:  J J van de Kamp; M F Niermeijer; K von Figura; M A Giesberts
Journal:  Clin Genet       Date:  1981-08       Impact factor: 4.438

10.  4-Methylumbelliferyl 2-acetamido-2-deoxy-alpha-D-glucopyranoside, a fluorogenic substrate for N-acetyl-alpha-D-glucosaminidase.

Authors:  P Chow; B Weissmann
Journal:  Carbohydr Res       Date:  1981-10-01       Impact factor: 2.104

View more
  15 in total

1.  Molecular defects in Sanfilippo syndrome type B (mucopolysaccharidosis IIIB).

Authors:  C E Beesley; M Jackson; E P Young; A Vellodi; B G Winchester
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease).

Authors:  J de Ruijter; L Broere; M F Mulder; A T van der Ploeg; M E Rubio-Gozalbo; S B Wortmann; G Visser; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2013-10-31       Impact factor: 4.982

3.  Sanfilippo type B syndrome: five patients with an R565P homozygous mutation in the alpha-N-acetylglucosaminidase gene from the Okinawa islands in Japan.

Authors:  Yasutsugu Chinen; Takaya Tohma; Yoshinori Izumikawa; Hiroyuki Uehara; Takao Ohta
Journal:  J Hum Genet       Date:  2005-06-03       Impact factor: 3.172

4.  Ensemble variant interpretation methods to predict enzyme activity and assign pathogenicity in the CAGI4 NAGLU (Human N-acetyl-glucosaminidase) and UBE2I (Human SUMO-ligase) challenges.

Authors:  Yizhou Yin; Kunal Kundu; Lipika R Pal; John Moult
Journal:  Hum Mutat       Date:  2017-06-27       Impact factor: 4.878

5.  Correction of mucopolysaccharidosis type IIIb fibroblasts by lentiviral vector-mediated gene transfer.

Authors:  Guglielmo R D Villani; Antonia Follenzi; Borghina Vanacore; Carmela Di Domenico; Luigi Naldini; Paola Di Natale
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

6.  IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.

Authors:  Xiang Li; Paul E Massa; Adedayo Hanidu; Gregory W Peet; Patrick Aro; Ann Savitt; Sheenah Mische; Jun Li; Kenneth B Marcu
Journal:  J Biol Chem       Date:  2002-09-06       Impact factor: 5.157

7.  Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype.

Authors:  Marlies J Valstar; Hennie T Bruggenwirth; Renske Olmer; Ron A Wevers; Frans W Verheijen; Ben J Poorthuis; Dicky J Halley; Frits A Wijburg
Journal:  J Inherit Metab Dis       Date:  2010-09-18       Impact factor: 4.982

8.  Structural and mechanistic insight into the basis of mucopolysaccharidosis IIIB.

Authors:  Elizabeth Ficko-Blean; Keith A Stubbs; Oksana Nemirovsky; David J Vocadlo; Alisdair B Boraston
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-28       Impact factor: 11.205

9.  Mucopolysaccharidosis type IIIB (MPS IIIB) masquerading as a behavioural disorder.

Authors:  Jacqueline Brady; Aditi Trehan; Dennis Landis; Camilo Toro
Journal:  BMJ Case Rep       Date:  2013-05-08

Review 10.  Sanfilippo syndrome: a mini-review.

Authors:  M J Valstar; G J G Ruijter; O P van Diggelen; B J Poorthuis; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.